Three birds with one stone: Herein we report the discovery of pan‐PPAR agonists 6 and 9, which are based on the resveratrolscaffold and which have balanced EC50 values toward three PPAR subtypes, α, γ, and δ. We evaluated their biological activity in vivo and carried out dockingstudies as well.